Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Prediction of Risk for Adverse Pregnancy Outcomes in Women with Sickle Cell Disease

A. Kinga Malinowski, MD MSc, FRCSC, Kevin H. M. Kuo, MDMSc,FRCPC, George A. Tomlinson, PhD BSc, MSc, Richard Ward, MSc, MRCP, FRCPath, Nadine Shehata, MDFRCPC,MSc

Blood (2019) 134 (Supplement_1): 1009.

https://doi.org/10.1182/blood-2019-130087

Published: 2019

Journal Articles

JAK2V617F-Mediated Endothelial Dysfunction Promotes Congestive Heart Failure in a Murine Model of Myeloproliferative Neoplasm

Melissa Castiglione, BS, Christopher Mazzeo, BS, Ya-Ping Jiang, Juei-Suei Chen, Wei Yin, Richard Lin, Huichun Zhan, MD

Blood (2019) 134 (Supplement_1): 7.

https://doi.org/10.1182/blood-2019-131372

Published: 2019

Journal Articles

Relationship between Vaso-Occlusive Crises and Important Complications in Sickle Cell Disease Patients

Miranda Bailey, Ajibola Abioye, George Morgan, Tom Burke, MSc, Tim Disher, Stephen Brown, Ashley Bonner, Eleonore Herquelot, Ludovic Lamarsalle, Fanny Raguideau

Blood (2019) 134 (Supplement_1): 2167.

https://doi.org/10.1182/blood-2019-131721

Published: 2019

Journal Articles

Diagnostic Delay and Characterization of the Clinical Prodrome in AL Amyloidosis: Data from 1,313 US Commercially Insured Patients between 2006-2018

Laura L Hester, PhD MSc, Dina M Gifkins, PhD MPH, Kevin M Bellew, MS, MA, Jessica Vermeulen, MD PhD, Jordan M Schecter, MD, Frank J DeFalco, Brendan M Weiss, MD

Blood (2019) 134 (Supplement_1): 5517.

https://doi.org/10.1182/blood-2019-124250

Published: 2019

Journal Articles

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Erica Sparkenbaugh, PhD BS, Kathryn Wilson, BS, Malgorzata Kasztan, PhD, David M. Pollock, PhD, Keith R. McCrae, MD, Rafal Pawlinski, PhD

Blood (2018) 132 (Supplement 1): 268.

https://doi.org/10.1182/blood-2018-99-116526

Published: 2018

Journal Articles

Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence

Clark Paramore, MPH, Amanda Kong, MPH, Sachiyo Minegishi, Weiliang Shi, PhD

Blood (2018) 132 (Supplement 1): 4811.

https://doi.org/10.1182/blood-2018-99-118874

Published: 2018

Journal Articles

Targeting Leukocyte Derived MPO in Heart Failure

David Wald, PhD MD, Kalpana Gupta, PhD, Yuan Lu, MD, Stephen Moreton

Blood (2017) 130 (Supplement 1): 3570.

https://doi.org/10.1182/blood.V130.Suppl_1.3570.3570

Published: 2017

Journal Articles

Average Monthly Cost of Iron Chelator Treatment in Adult Patients with Sickle Cell Disease

Samip Master, MD, Richard Preston Mansour, MD

Blood (2016) 128 (22): 4858.

https://doi.org/10.1182/blood.V128.22.4858.4858

Published: 2016

Journal Articles

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Nancy Robitaille, MD, Yves D. Pastore, MD, Anne-Julie Landry, M.Sc, Catherine Latour, MD, Josée Lavoie, M.Sc, Geneviève Laflamme, M.Sc, Josée Perreault, PhD, Maryse St-Louis, PhD

Blood (2016) 128 (22): 2486.

https://doi.org/10.1182/blood.V128.22.2486.2486

Published: 2016

Journal Articles

Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease

Erica M. Sparkenbaugh, Pichika Chantrathammachart, Kasemsiri Chandarajoti, Nigel Mackman, Nigel S. Key, Rafal Pawlinski

Blood (2016) 127 (10): 1371–1373.

https://doi.org/10.1182/blood-2015-11-681114

Published: 2016

Journal Articles

Congenital Dyserythropoietic Anemia Type 1: A New Variant Pathogenic CDAN1 Mutation

Jenny McDaniel, MD, Stuart Cramer, D.O.

Blood (2015) 126 (23): 4551.

https://doi.org/10.1182/blood.V126.23.4551.4551

Published: 2015

Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD

Blood (2015) 126 (23): 3279.

https://doi.org/10.1182/blood.V126.23.3279.3279

Published: 2015

Journal Articles

The Evaluation of Cardiac Disorders and Systemic Hypertension in JAK2 V617F Positive Patients at a Multicenter Institution

Abuzar Moradi Tuchayi, MD, Sid Hemant Sheth, DO, MPH, Roy E. Smith, MD

Blood (2014) 124 (21): 5560.

https://doi.org/10.1182/blood.V124.21.5560.5560

Published: 2014

Journal Articles

Implementation of a European Cohort to Follow Sickle Cell Children and Adults Treated with Hydroxycarbamide

Mariane De Montalembert, MD, Frédéric Galacteros, Jean Antoine Ribeil, MD PhD, Uwe Kordes, MD MRCP, Jean Benoit Arlet, MD PhD, M Dimopoulou, MD, V Komninaka, MD, Pablo Bartolucci, MD PhD, Anoosha Habibi, Valentine Brousse, MD, Justine Gellen, MD, Stephen Lobitz, MD, Ersi Voskaridou, MD

Blood (2014) 124 (21): 564.

https://doi.org/10.1182/blood.V124.21.564.564

Published: 2014

Journal Articles

Profiling Of Polycyclic Aromatic Hydrocarbons-Induced Genotoxicity In Peripheral Blood Stem Cells and Bone Marrow Mesenchymal Stem Cells

Hwan-Young Kim, Hye-Ran Kim, PhD, Trang Nguyen Thi Dai, Hee-Jo Baek, MD, PhD, Jae-Dong Moon, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Hoon Kook, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 1221.

https://doi.org/10.1182/blood.V122.21.1221.1221

Published: 2013

Journal Articles

Sickle Cell Disease Glomerulopathy In Five Subsaharian African Countries: Results Of The Cadre Study

Brigitte Ranque, MD, PhD, Marie Michèle Thiam, MD, Msc, Dapa Aly Diallo, MD, Saliou Diop, MD, MSC, Ibrahima Diagne, MD, Ibrahima Sanogo, MD, Gustave Koffi, MD, Kouakou Boidy, MD, Luc Sica, MD, Guillaume Wamba, MD, Suzanne Belinga, MD, Pierre Louis Tharaux, MD, PhD, Xavier Jouven, MD, PhD

Blood (2013) 122 (21): 779.

https://doi.org/10.1182/blood.V122.21.779.779

Published: 2013

Journal Articles

Changes in Plasma TGF-β1 Levels in a Murine Model of Aortic Stenosis (Surgical Constriction of the Ascending Aorta) in C57Bl/6 (wild-type) Mice and Mice with a Targeted Deletion of Platelet TGF-β1

Wei Wang, MD, Alexander Meyer, Barry S. Coller, MD, Jasimuddin Ahamed, PhD

Blood (2012) 120 (21): 1065.

https://doi.org/10.1182/blood.V120.21.1065.1065

Published: 2012

Journal Articles

Mice with Megakaryocyte-Specific Deletion of TGF-β1 Are Partially Protected From Developing Cardiac Fibrosis and Systolic Dysfunction in a Pressure Overload Model

Alexander Meyer, Wei Wang, MD, Jay L. Degen, PhD, Barry S. Coller, MD, Jasimuddin Ahamed, PhD

Blood (2011) 118 (21): 362.

https://doi.org/10.1182/blood.V118.21.362.362

Published: 2011

Journal Articles

Assessment of Free Light Chains in the Ascites and Pleural Effusion in Patients with Multiple Myeloma: A Report of 2 Cases

Sawsan Rashdan, MD, Sherif Farag, MD, PhD, FRACP, FRCPA, Rafat Abonour, MD, Attaya Suvannasankha, MD

Blood (2011) 118 (21): 5078.

https://doi.org/10.1182/blood.V118.21.5078.5078

Published: 2011

Journal Articles

Prolonged QTc Interval Is Common In Patients with Sickle Cell Disease and Has An Inverse Relationship to Hemoglobin and Hematocrit: Results From CSSCD

Ruchika Goel, MD, MPH, Sudha Rajderkar, MS, Rema Padman, PhD, Lakshmanan Krishnamurti, MD

Blood (2010) 116 (21): 2675.

https://doi.org/10.1182/blood.V116.21.2675.2675

Published: 2010

NARROW

Prediction of Risk for Adverse Pregnancy Outcomes in Women with Sickle Cell Disease

JAK2V617F-Mediated Endothelial Dysfunction Promotes Congestive Heart Failure in a Murine Model of Myeloproliferative Neoplasm

Relationship between Vaso-Occlusive Crises and Important Complications in Sickle Cell Disease Patients

Diagnostic Delay and Characterization of the Clinical Prodrome in AL Amyloidosis: Data from 1,313 US Commercially Insured Patients between 2006-2018

High Molecular Weight Kininogen Contributes to End-Organ Damage and Mortality in a Mouse Model of Sickle Cell Disease

Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence

Targeting Leukocyte Derived MPO in Heart Failure

Average Monthly Cost of Iron Chelator Treatment in Adult Patients with Sickle Cell Disease

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease

Congenital Dyserythropoietic Anemia Type 1: A New Variant Pathogenic CDAN1 Mutation

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

The Evaluation of Cardiac Disorders and Systemic Hypertension in JAK2 V617F Positive Patients at a Multicenter Institution

Implementation of a European Cohort to Follow Sickle Cell Children and Adults Treated with Hydroxycarbamide

Profiling Of Polycyclic Aromatic Hydrocarbons-Induced Genotoxicity In Peripheral Blood Stem Cells and Bone Marrow Mesenchymal Stem Cells

Sickle Cell Disease Glomerulopathy In Five Subsaharian African Countries: Results Of The Cadre Study

Changes in Plasma TGF-β1 Levels in a Murine Model of Aortic Stenosis (Surgical Constriction of the Ascending Aorta) in C57Bl/6 (wild-type) Mice and Mice with a Targeted Deletion of Platelet TGF-β1

Mice with Megakaryocyte-Specific Deletion of TGF-β1 Are Partially Protected From Developing Cardiac Fibrosis and Systolic Dysfunction in a Pressure Overload Model

Assessment of Free Light Chains in the Ascites and Pleural Effusion in Patients with Multiple Myeloma: A Report of 2 Cases

Prolonged QTc Interval Is Common In Patients with Sickle Cell Disease and Has An Inverse Relationship to Hemoglobin and Hematocrit: Results From CSSCD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only